Pharmaceuticals · SOUTH SAN FRANCISCO, CA, United States
$84.19
-0.34% (-$0.29)2026-07-09
Smart-Money SignalDistribution · 40/100— Insiders are net sellers over 90 days (-$13.9M, 50 sales vs 29 buys)
Revenue$19.4M
Net Income-$206.0M
EPS$-1.67
Market Cap$10.5B
Price Performance
Historical data including institutional events
Company Profile
R
Robert Blum
CEO & Executive Director
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
